Havrix 720 unit/0.5 ML syringe 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FXGZS
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,169
Award facts
- Contract value 100% obligated
- $2,168.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, received a firm fixed-price delivery order from the Defense Logistics Agency (DLA) on August 27, 2025, for HAVRIX 720 Unit/0.5 ML syringes valued at $2,168.80. This delivery order was issued without a set-aside designation and carries an ultimate completion date of August 28, 2025, with performance to be completed at the awardee's Park Ridge, Illinois location. HAVRIX is a hepatitis A vaccine commonly used by military and federal healthcare facilities to support immunization programs across the Department of Defense.
This delivery order was issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which is valued at $499.999 billion and remains valid through November 2026. This IDC enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items, including vaccines, biologics, prescription medications, and medical consumables supporting military health facilities worldwide. DMS Pharmaceutical Group has established itself as a key supplier within the federal pharmaceutical supply chain, leveraging its woman-owned small business status and specialized pharmaceutical distribution capabilities to serve Defense Department healthcare needs.
Quick answers
Who was awarded contract SPE2DB25FXGZS?
SPE2DB25FXGZS was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 27, 2025.
How much is contract SPE2DB25FXGZS worth?
The government has obligated $2,169 on SPE2DB25FXGZS.
Is contract SPE2DB25FXGZS an order under another contract?
Yes. SPE2DB25FXGZS is a delivery order under SPE2DB25D9306, an indefinite delivery contract.
Was contract SPE2DB25FXGZS competed?
The extent of competition for SPE2DB25FXGZS was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award